Carcinoma Breast: A study in an urban Hospital ... - Orion Group
Carcinoma Breast: A study in an urban Hospital ... - Orion Group
Carcinoma Breast: A study in an urban Hospital ... - Orion Group
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Orig<strong>in</strong>al Article<br />
<strong>Carc<strong>in</strong>oma</strong> <strong>Breast</strong>: A <strong>study</strong> <strong>in</strong> <strong>an</strong> urb<strong>an</strong> <strong>Hospital</strong>,B<strong>an</strong>gladesh<br />
Ali Y, Kibria SG, lslam MN, Udd<strong>in</strong> MM, Chowdhury ASMJ<br />
Summary<br />
A cl<strong>in</strong>ical <strong>study</strong> of old <strong>an</strong>d new 43 cases of<br />
carc<strong>in</strong>oma (Ca) breast were carried out at<br />
Radiotherapy Department, faridpur Medical<br />
College <strong>Hospital</strong>, faridpur from J<strong>an</strong>uary '99 to<br />
June 2001 with a view to see the <strong>in</strong>itial stage<br />
at presentation, to evaluate the modes of<br />
treatment, response to treatment <strong>an</strong>d f<strong>in</strong>d out<br />
the survival period after presentation. All the<br />
cases were under follow up. Male 2.32% <strong>an</strong>d<br />
female 97.68%, peak age <strong>in</strong>cidence were (31-<br />
45 years) 48.84%, cytologically proved<br />
90.70%, stages were I, II, III <strong>an</strong>d IV 13.95%,<br />
53.49%, 18.61 % <strong>an</strong>d13.95% respectively.<br />
Infiltrat<strong>in</strong>g ductal carc<strong>in</strong>oma 79.06%, adenocarc<strong>in</strong>oma<br />
were 4.65%, medullary carc<strong>in</strong>oma<br />
4.65%. Treatment completed only <strong>in</strong> 39.53%<br />
of cases. No evidence of metastasis were<br />
found <strong>in</strong> 69.72% cases after completion of<br />
treatment, <strong>an</strong>d one year survival were 95.35%,<br />
2.5 years survival were 81.39% <strong>an</strong>d more th<strong>an</strong><br />
5 years survival were 4.65% <strong>an</strong>d expired<br />
18.61 %.<br />
Introduction<br />
<strong>Breast</strong> c<strong>an</strong>cer is one of the most common<br />
malign<strong>an</strong>t lesions <strong>an</strong>d lead<strong>in</strong>g causes of death<br />
from c<strong>an</strong>cer <strong>in</strong> women 1 . The <strong>in</strong>cidence of<br />
different types of breast lesions varies from<br />
country to country depend<strong>in</strong>g on<br />
socioeconomic condition, liv<strong>in</strong>g style, marital<br />
1. Dr. Md. Yeaqub Ali, FCPS<br />
(Radiotherapy), Asst. Professor, Radiotherapy<br />
Department, Faridpur Medical College <strong>an</strong>d<br />
hospital (FMCH), Faridpur<br />
2. Dr. Syed Golam Kibria, MPhil<br />
(Pathology), Asst. Professor, Pathology Dept,<br />
Faridpur Medical College (FMC).<br />
3. Dr. Md. Nasimul Islam, MPhil<br />
(Pathology), Asst. Professor, Pathology<br />
Department, FMC.<br />
4. Dr. Md. Mokhles Udd<strong>in</strong>, FCPS<br />
(Radiotherapy), Associate Professor,<br />
Radiotherapy Department, Khulna Medical<br />
College, Khulna.<br />
5. Dr. A.S.M. Jah<strong>an</strong>gir Chowdhury, MS<br />
(Ortho.), Asst. Professor, Orthopaedic Surgery<br />
Dept. FMCH, Faridpur.<br />
The ORION Vol. 12, May 2002<br />
age, frequency of pregn<strong>an</strong>cy <strong>an</strong>d lactation<br />
habit 2 . breast c<strong>an</strong>cer affects about one million<br />
women per year world wide. In general 1 <strong>in</strong><br />
12 women are affected.<br />
Only about 1% of breast c<strong>an</strong>cer occurs <strong>in</strong><br />
males -about the same ratio as the amount of<br />
breast tissue. 4<br />
<strong>Breast</strong> c<strong>an</strong>cer is currently viewed as a<br />
systemic disorder, right from is outset varies<br />
widely <strong>in</strong> behavior with<strong>in</strong> the same<br />
histological type. Hence, the need for a multidiscipl<strong>in</strong>ary<br />
approach where locoregional<br />
treatment (surgery <strong>an</strong>d radiotherapy) is<br />
accomp<strong>an</strong>ied by systemic (chemotherapy <strong>an</strong>d<br />
hormone therapy) 5<br />
Surgery, cytotoxic chemotherapy,<br />
radiotherapy <strong>an</strong>d hormone therapy c<strong>an</strong><br />
provide the hope of cure <strong>in</strong> early cases.<br />
Materials <strong>an</strong>d methods<br />
This prospective <strong>study</strong> presents 43 cases of<br />
carc<strong>in</strong>oma breast, aged from 25 to 80 years.<br />
They attended at Radiotherapy out patient<br />
department, Faridpur Medical College<br />
<strong>Hospital</strong> from J<strong>an</strong>uary '99 to June '01. All the<br />
cases were referred from different<br />
departments of this hospital <strong>an</strong>d other<br />
hospitals. Thorough physical exam<strong>in</strong>ations<br />
were done <strong>an</strong>d relev<strong>an</strong>t data were collected<br />
from case sheets of the hospital records <strong>an</strong>d<br />
all efforts were made to obta<strong>in</strong> maximum<br />
possible <strong>in</strong>formation regard<strong>in</strong>g the duration of<br />
illness, mode of onset, cl<strong>in</strong>ical f<strong>in</strong>d<strong>in</strong>gs,<br />
evidence of metastasis, <strong>in</strong>vestigations<br />
procedures carried out, such as rout<strong>in</strong>e<br />
<strong>in</strong>vestigations; like rout<strong>in</strong>e blood exam<strong>in</strong>ation,<br />
X-ray chest, USG of the whole abdomen,<br />
bone sc<strong>an</strong>, liver sc<strong>an</strong>, C.T. sc<strong>an</strong>, cytology of<br />
the tumour cell (histo-pathology or f<strong>in</strong>e<br />
needle aspiration cytology etc.) <strong>an</strong>d confirmed<br />
the diagnosis, stag<strong>in</strong>g of the tumor were done<br />
by cl<strong>in</strong>ical stag<strong>in</strong>g of breast c<strong>an</strong>cer system.<br />
Out of 43 cases surgery were done <strong>in</strong> 42 cases<br />
<strong>an</strong>d comb<strong>in</strong>ation cy toxic chemotherapy<br />
(CMF) <strong>an</strong>d loco- regional radiotherapy were<br />
www.orion-group.net/journals
Orig<strong>in</strong>al Article<br />
provided only <strong>in</strong> 1 7 cases. Among 43 cases 4<br />
patients were given neo-adjuv<strong>an</strong>t<br />
chemotherapy (CAF therapy) followed by<br />
surgery after do<strong>in</strong>g stag<strong>in</strong>g (from stage III A<br />
to stage II B) then cont<strong>in</strong>uation of cytotoxic<br />
chemotherapy (CMF cyclophosphamide,<br />
methotrexate <strong>an</strong>d 5 Fluro-uracil) +<br />
locoregional radiotherapy <strong>an</strong>d hormone<br />
therapy (Antiestrogen, Tab. Tamoxifen 20 mg<br />
orally daily for 5 years).<br />
Table -I: Distribution of sex (N = 43)<br />
Sex<br />
Number<br />
of Percentage(%)<br />
Patients<br />
Female 42 97.68<br />
Male 01 2.32<br />
All the documents were' recorded ,<strong>in</strong><br />
<strong>in</strong>dividual pr<strong>in</strong>ted sheets. At the end of<br />
treatment, they were evaluated periodically.<br />
Results<br />
The f<strong>in</strong>d<strong>in</strong>gs of this <strong>study</strong> are depicted <strong>in</strong><br />
table I-VIII (Sex, age, cl<strong>in</strong>ical stage, methods<br />
of diagnosis, histopathological types,<br />
treatment received primary response to<br />
treatment, years of survival respectively.<br />
The relationship of carc<strong>in</strong>oma of the breast to the<br />
quadr<strong>an</strong>ts of the breast.<br />
Paget's disease of the nipple<br />
The ORION Vol. 12, May 2002<br />
www.orion-group.net/journals
Orig<strong>in</strong>al Article<br />
The ORION Vol. 12, May 2002<br />
www.orion-group.net/journals
Orig<strong>in</strong>al Article<br />
<strong>an</strong>other. Comb<strong>in</strong>ation of above treatments c<strong>an</strong><br />
provide the hope of cure <strong>in</strong> early cases 7 .<br />
The addition of mastectomy to chemotherapy<br />
plus radiotherapy improved dist<strong>an</strong>t dieases<br />
<strong>an</strong>d overall survival <strong>in</strong> patients with a cl<strong>in</strong>ical<br />
complete or partial response to <strong>in</strong>duction<br />
chemotherapy. 8<br />
In our <strong>study</strong>, <strong>in</strong>filtrat<strong>in</strong>g ductal carc<strong>in</strong>oma,<br />
metastatic adenocarc<strong>in</strong>oma, medullary<br />
carc<strong>in</strong>oma were 97.07%, 4.65% <strong>an</strong>d 14.65%<br />
respectively. There observations are <strong>in</strong><br />
agreement with the f<strong>in</strong>d<strong>in</strong>gs of A. Rouf <strong>an</strong>d S.<br />
Sham<strong>in</strong> <strong>in</strong> our country 9 <strong>an</strong>d of Berg <strong>an</strong>d<br />
Huntter 10 <strong>in</strong> USA, where ductal carc<strong>in</strong>oma<br />
appeared to be 75.4% <strong>an</strong>d lobular carc<strong>in</strong>oma<br />
7.3% among all the malign<strong>an</strong>t lesions. The<br />
results of treatment of carc<strong>in</strong>oma breast <strong>in</strong> our<br />
country is not highly appreciat<strong>in</strong>g due to very<br />
few radiotherapy center, late stage of<br />
diagnosis, poverty, lack of knowledge <strong>an</strong>d<br />
ignor<strong>an</strong>ce. Effective treatment as well as<br />
prevention of c<strong>an</strong>cer <strong>in</strong> not possible most of<br />
the time. Screen<strong>in</strong>g represents <strong>an</strong> alternative<br />
approach to try to reduce mortality from<br />
breast c<strong>an</strong>cer 11 . Early detection of breast<br />
c<strong>an</strong>cer is of vital import<strong>an</strong>ce for <strong>in</strong>creas<strong>in</strong>g<br />
survival rate <strong>an</strong>d decreas<strong>in</strong>g mortality rate <strong>in</strong><br />
breast c<strong>an</strong>cer.<br />
In our <strong>study</strong>, after a medi<strong>an</strong> follow up of 21<br />
mothers (R<strong>an</strong>ge, 12 -30 months), over all<br />
survival were 9 months (r<strong>an</strong>ge 13 -30 months).<br />
Conclusions<br />
The CMF comb<strong>in</strong>ation chemotherapy is safe<br />
<strong>an</strong>d effective for a non adjuv<strong>an</strong>t sett<strong>in</strong>g <strong>in</strong><br />
breast c<strong>an</strong>cer. A longer follow-up is necessary<br />
for the end po<strong>in</strong>t results. 15 years follow up is<br />
suggested.<br />
References<br />
1. Roasi j. In <strong>Breast</strong>, Ackerm<strong>an</strong>,s Surgical<br />
Pathology, fifth editon. St Louis: CY<br />
MosbyComp<strong>an</strong>y, 1989. PP- 1193-1255<br />
II -16.<br />
2. Robb<strong>in</strong> SL. Karnar V. In: Basic Pathology,<br />
Fourth edition. London: WB Saunders, 1987;<br />
PP-657-669.<br />
3. The square, Health Care, Quaterly journal,<br />
The square Pharmaceuticals Ltd. B<strong>an</strong>gladesh,<br />
3rd quarter, vol. 6, September 1998, Page:<br />
4. Water <strong>an</strong>d Miller's Text Book of<br />
Radiotherapy, Radiation Physics, therapy <strong>an</strong>d<br />
oncology, 5th edition, Churchill<br />
Uv<strong>in</strong>gstone, Ed<strong>in</strong>burg, London, Madrid,<br />
Melbourne, Now York, Tokyo, 1993,<br />
P383.&P-398-99.<br />
5. Bresadola-F, Maacotti-E; An<strong>an</strong>ia-G,<br />
Current tre<strong>an</strong>ds <strong>an</strong>d therapeutic strategies <strong>in</strong><br />
breast carc<strong>in</strong>oma. Ann-Ital-Chir, 1999<br />
May-june; 70(3):317-9<br />
6. Flem<strong>in</strong>g -RY; Asmar-L; Buzdar-AU; MC<br />
Neese-MD; Ames-FC; Ross-MI: S<strong>in</strong>gletary-<br />
SE, Effectiveness of mastectomy<br />
by response to <strong>in</strong>duction chemotherapy for<br />
control <strong>in</strong> <strong>in</strong>flammatory breast c<strong>an</strong>cer. Annsurg-oncol.<br />
1997 sep: 4(6): 452-61<br />
7. Professor A.N.M. Atai Rabbi, Dr. Dayem<br />
udd<strong>in</strong>, c<strong>an</strong>cer <strong>Breast</strong>; over view of modern<br />
m<strong>an</strong>agement, Medic<strong>in</strong>e Digest, Volume<br />
I, Number 4, April, june 2001, Page: 6- 9.<br />
8. A Rout S, Sham<strong>in</strong>, S.M. Ali,<br />
Histopathology of <strong>Breast</strong> Lesions: An<br />
Analysis, journal of B<strong>an</strong>gladesh College of<br />
Physici<strong>an</strong>s <strong>an</strong>d Surgeons, May 1997, Vol.<br />
IS, No.2, Page: 54-58.<br />
9. Belg. john WS Hutter Robert VB. SEER<br />
Population Based Data. Supplement of <strong>Breast</strong><br />
c<strong>an</strong>cer, 1995, PP-257-265.<br />
10. Blamey RW, Wilson ARM Patrick j.<br />
Dixon jM, Screen<strong>in</strong>g of breast c<strong>an</strong>cer, ABC<br />
of breast diseases. BMj 1994: 309: 1076.<br />
The ORION Vol. 12, May 2002<br />
www.orion-group.net/journals